DARE Daré Bioscience, Inc.

0.82-0.01 (-0.74%)
Close: August 23, 2019

0.840.02 (+1.83%)
Pre-market

Quote

Previous Close
$0.82
Day Range
$0.80-$0.87
52 Week Range
$0.60-$3.25
Volume
59,609
Avg Volume
175,567
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$13.68M
Enterprise Value (EV)
$6.98M
PE Ratio
-
EV/EBITDA
-0.60
Price/Sales
-
Price/Book
2.03
PEG Ratio
0.08

Financials

Revenue
-
Gross Profit
-$2.44K
EBITDA
-$11.69M
EPS, ttm
-$1.04
Profit Margin
-
Revenue/Employee
-
Next Earnings Date
11/12/2019 (79 days)
Debt to Equity
-
Debt
$101.77K
Cash
$6.81M
Net Debt
-

Performance

Beta
0.89
200 Day Moving Avg
$0.91
50 Day Moving Avg
$0.80
52 Week Change
-20.39%
YTD Change
10.40%
1 Month Change
9.33%
3 Month Change
-6.14%
6 Month Change
-2.38%
1 Year Change
-20.39%
2 Year Change
-77.83%
5 Year Change
-98.49%

Share Count

Shares Outstanding
16.7M
Float
13.6M
Restricted Shares
3.1M
Restricted Shares, %
18.47%

Daré Bioscience, Inc. Company Details

Sector: Health Technology

Industry: Biotechnology

CEO: Sabrina Martucci Johnson

Website: http://www.darebioscience.com

Description: Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert, and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Employees: 14